Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AMG416
AMG416
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
Endpoints
Thu, 08/25/16 - 09:38 am
secondary hyperparathyroidism
Amgen
FDA
AMG416
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Fierce Biotech
Thu, 02/26/15 - 10:26 am
Amgen
AMG416
Sensipar
secondary hyperparathyroidism